Stock Analysis of Catalent Inc (CTLT) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code CTLT
Close 55.48
Change -0.490 / 0.875 %
Volume 1522.35 K
Vol Change 764179 / 100.79 %
IndustryDrug Manufacturers-Specialty & Generic
SectorHealthcare
AIO Strength Index
Technical StrengthMild Bearish
Growth Index Low Growth Stock
Value Index Very Low Value Stock
Profitability Index Poor Profitability Stock
Stability Index Low Stability Stock


Fundamental View of Catalent Inc


Highs/Lows of Catalent Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week56.39 1.61 % 1.58 % 56.4255.1910-Jun-2414-Jun-24
Two Week53.79 3.14 % 2.92 % 56.5453.8507-Jun-2403-Jun-24
One Month55.52 0.072 % 3.52 % 56.5453.5107-Jun-2429-May-24
Three Month56.7 2.15 % 5.46 % 57.199953.5111-Apr-2429-May-24
Six Months41.36 34.14 % 15.09 % 60.240.8505-Feb-2415-Dec-23
One year42.09 31.81 % 24.22 % 60.231.800105-Feb-2401-Nov-23
Two year104.29 46.80 % 45.41 % 74.4931.4503-Mar-2315-May-23
Five year49.69 11.65 % 88.14 % 108.531.0418-Aug-2218-Mar-20


Technical View of Catalent Inc






Charts of Catalent Inc


Returns of Catalent Inc with Peers
Period / StockCTLTVTRSRDYELANCRL
1 Week-1.61%-2.87%0.687%-0.988%-2.48%
1 Mth-0.072%-8.71%3.13%5.62%-10.03%
3 Mth-2.15%-13.96%-4.77%14.48%-19.59%
6mth34.14%-2.12%7.74%30.94%-8.63%
1 Year31.81%4.20%24.50%83.05%0.988%
2 Year-46.80%-1.45%29.90%-13.73%-0.0143%
5 Years11.65%-40.25%93.82%-43.57%61.87%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Catalent Inc with Peers
Ratio / StockCTLTVTRSRDYELANCRL
PE-9.07-13.070.215-6.8324.22
P/B2.440.5910.04551.343.15
ROA-10.75-1.9315.77-8.765.66
ROE-26.97-4.5221.73-19.5413.19
Debt To Equity0.8800.8900.0640.9280.859
Revenue4802.00 M
0.539 %
15465.60 M
4.90 %
279164 M
13.54 %
4367.00 M
1.15 %
4215.78 M
6.03 %
Net Income499000 K
3.85 %
1831.50 M
11.89 %
55684.00 M
23.54 %
-1144.00 M
1445.95 %
474950 K
2.32 %


Technicals of Catalent Inc with Peers
Technical / StockCTLTVTRSRDYELANCRL-
ADX23.7121.2919.3945.0024.55
CMF-0.079-0.117-0.1280.1110.0452
MFI61.7449.8556.2775.1032.72
RSI50.4030.7354.5762.9537.90
MACD Abv SignalTrueTrueTrueFalseTrue
Price Above 50 MAFalseFalseTrueTrueFalse-
Price Above 200 MATrueFalseTrueTrueFalse-


About : Catalent Inc


Address : 14 Schoolhouse Road, Somerset, NJ, United States, 08873
Tel : 732 537 6200
URL : https://www.catalent.com
Code : CTLT, ISIN : US1488061029, Exchange : NYSE, Country : USA
Fiscal Year End : June
IPO date : 31_Jul_2014
Employee Count : 18000

Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates in two segments, Biologics, and Pharma and Consumer Health. The Biologics segment provides formulation, development, and manufacturing for biologic proteins, cell gene, and other nucleic acid therapies; pDNA, iPSCs, oncolytic viruses, and vaccines; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, and cartridges; and analytical development and testing services for large molecules. The Pharma and Consumer Health segment offers formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations; and oral, nasal, inhaled, and topical dose forms. This segment also provides clinical supply services through manufacturing, packaging, storage, distribution, and inventory management for small-molecule drugs, protein-based biologics, and cell and gene therapies in clinical trials; and pre-clinical screening, formulation, analytical development, and current good manufacturing practices manufacturing at clinical and commercial scale for softgel capsule, Zydis fast-dissolve tablets, oral solid-dose formats, dry powder inhalers, and nasal delivery devices. The company also offers FlexDirect direct-to-patient and FastChain demand-led clinical supply solutions; fill and finish operations for injectable products; and integrated development and product supply chain solutions. It serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. The company was founded in 1933 and is headquartered in Somerset, New Jersey.


Note : All Data Generated at the End of Trading Hours (EOD Data)